Addition of a clinical pharmacist practitioner to an inpatient addiction triage team and related medication outcomes

IntroductionAt a Veterans Affairs Medical Center (VAMC), a clinical pharmacist practitioner (CPP) was added to an inpatient addiction triage team in August 2019 to provide education and recommendations regarding medications for alcohol use disorder (MAUD) and opioid use disorder (MOUD). Before the a...

Full description

Saved in:
Bibliographic Details
Published in:The mental health clinician 2022-08, Vol.12 (4), p.219-224
Main Authors: Ehrhard, Kim, Colvard, Michelle, Brabson, Jennifer
Format: Article
Language:English
Subjects:
acamprosate
addiction consult
buprenorphine
buprenorphine/naloxone
clinical pharmacist
clinical pharmacist practitioner
disulfiram
medication treatment for alcohol use disorder
medication treatment for opioid use disorder
naloxone
naltrexone
Original Research
pharmacist
substance use disorder
topiramate
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:IntroductionAt a Veterans Affairs Medical Center (VAMC), a clinical pharmacist practitioner (CPP) was added to an inpatient addiction triage team in August 2019 to provide education and recommendations regarding medications for alcohol use disorder (MAUD) and opioid use disorder (MOUD). Before the addition of the CPP, missed opportunities for MAUD and MOUD education and prescribing prior to discharge on non-psychiatric units were observed. MethodsThis was a single-center, single-site, retrospective, observational cohort study with a primary objective to compare initiation rates of MAUD/MOUD 12 months before and after the addition of the CPP to the addiction triage team. Secondary end points included 90-day medication possession ratio, 1- and 3-month emergency department visit rates, 1- and 3-month hospital readmission rates, and opioid education and naloxone distribution interventions for eligible patients with a diagnosis of opioid use disorder. ResultsBoth statistically and clinically significant improvements in MAUD/MOUD initiation rates were found in the CPP intervention group compared with the historical control group (26.3% vs 4%, P 
ISSN:2168-9709
2168-9709
DOI:10.9740/mhc.2022.08.219